-
-
-
-
-
-
-
QIAGEN partners with NVIDIA to integrate AI into drug discovery platform
-
-
-
-
-
-
-
QIAGEN lowers 2026 outlook as QuantiFERON immigration testing drops
-
-
-
-
-
-
-
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
-
-
-
-
-
-
-
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth
-
-
-
-
-
-
-
QIAGEN to acquire Parse Biosciences for $225 million
-
-
-
-
-
-
-
QIAGEN receives FDA clearance for higher-throughput diagnostic system
-
-
-
-
-
-
-
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board
-
1,199,633 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

